Editorial: infliximab or adalimumab as first‐ or second‐line anti‐TNF—conflicting evidence—authors' reply
نویسندگان
چکیده
LINKED CONTENT This article is linked to Visuri et al and Haydek & Scott papers. To view these articles, visit https://doi.org/10.1111/apt.16525 https://doi.org/10.1111/apt.16555
منابع مشابه
Cost-effectiveness of adalimumab, infliximab or vedolizumab as first-line biological therapy in moderate-to-severe ulcerative colitis
BACKGROUND There are no head-to-head randomised controlled trials (RCTs) comparing the effectiveness of biologics in ulcerative colitis (UC). We aimed to assess the cost-effectiveness of adalimumab, infliximab and vedolizumab as first-line agents to induce clinical remission and mucosal healing (MH) in UC. METHODS We constructed a decision tree based on a payer's perspective in the USA to est...
متن کاملoutcome of switching to etanercept infliximab or adalimumab determines the The presence or absence of antibodies
http://ard.bmj.com/content/early/2010/11/09/ard.2010.135111.full.html Updated information and services can be found at: These include: References http://ard.bmj.com/content/early/2010/11/09/ard.2010.135111.full.html#ref-list-1 This article cites 26 articles, 13 of which can be accessed free at: P<P Published online November 10, 2010 in advance of the print journal. service Email alerting box at...
متن کاملAdalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
Fistulotomy alone induced remission in 85% of patients with simple perianal fistula without rectal inflammation. However, if active inflammation is present in the rectum, the risk of delayed healing or fecal incontinence increases after fistulotomy. Therefore, a noncutting seton placement is preferred, along with appropriate medical treatment when active inflammation is present. The introductio...
متن کاملAn indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
INTRODUCTION The aim of the study was to compare adalimumab or golimumab with infliximab in patients with moderately-to-severely active ulcerative colitis (UC). MATERIAL AND METHODS This paper was prepared according to the PRISMA guidelines. The systematic literature search was performed in PubMed, Embase, and Cochrane Library. No direct head-to-head comparisons for infliximab vs. adalimumab ...
متن کاملEditorial: CDH or DDH?
not be. It is generally accepted by medical professionals that the manifestation of multigenetic disease during the lifetime of a gene carrier depends on certain environmental factors. This hip disorder can develop and even be exacerbated when certain environmental factors are present, but can also recede without further intervention following elimination of those same factors at an early devel...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alimentary Pharmacology & Therapeutics
سال: 2021
ISSN: ['1365-2036', '0269-2813']
DOI: https://doi.org/10.1111/apt.16569